𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human erythropoietin therapy in children maintained by haemodialysis

✍ Scribed by Susan P. A. Rigden; Giovanni Montini; Max Morris; Kenneth G. A. Clark; George B. Haycock; Cyril Chantler; Ronald C. Hill

Publisher
Springer
Year
1990
Tongue
English
Weight
556 KB
Volume
4
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ LeΓ³n, Pedro; JimΓ©nez, Miguel; Barona, Pascual; SierrasesΓΊmaga, Luis πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant

Combination Therapy With Recombinant Hum
Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia
✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients